Pricing delay raises shortage of medicine, counterfeiting risks
• Federal cabinet yet to decide on proposals despite Drap recommending price revisions for 105 hardship-category medicines over two years ago • Prolonged shortages creating opportunities for illegal suppliers to fill the gap, chemists’…